[go: up one dir, main page]

ES2192199T3 - Ligandos de la familia eph biologicamente activos. - Google Patents

Ligandos de la familia eph biologicamente activos.

Info

Publication number
ES2192199T3
ES2192199T3 ES95916204T ES95916204T ES2192199T3 ES 2192199 T3 ES2192199 T3 ES 2192199T3 ES 95916204 T ES95916204 T ES 95916204T ES 95916204 T ES95916204 T ES 95916204T ES 2192199 T3 ES2192199 T3 ES 2192199T3
Authority
ES
Spain
Prior art keywords
biologically active
ligandos
eph
active family
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95916204T
Other languages
English (en)
Other versions
ES2192199T5 (es
Inventor
Samuel Davis
Nicholas Gale
Thomas H Aldrich
Peter C Maisonpierre
Mitchell Goldfarb
George D Yancopoulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regeneron Pharmaceuticals Inc
Original Assignee
Regeneron Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27499262&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2192199(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/299,567 external-priority patent/US5747033A/en
Application filed by Regeneron Pharmaceuticals Inc filed Critical Regeneron Pharmaceuticals Inc
Publication of ES2192199T3 publication Critical patent/ES2192199T3/es
Application granted granted Critical
Publication of ES2192199T5 publication Critical patent/ES2192199T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

SE IDENTIFICAN NUEVOS LIGANDOS QUE SE UNEN A LA FAMILIA DE RECEPTORES EPH, Y SE DESCRIBEN METODOS PARA OBTENER LOS LIGANDOS SOLUBLES EN FORMA BIOLOGICAMENTE ACTIVA. LOS CLONES DE C-DNA QUE CODIFICAN PARA ESTAS NUEVAS PROTEINAS PERMITEN LA PRODUCCION DE LAS PROTEINAS RECOMBINANTES, QUE SON UTILES PARA SUSTENTAR CELULAS NEURONALES Y OTRAS POBLACIONES CELULARES QUE PORTAN RECEPTORES.
ES95916204T 1994-04-04 1995-04-04 Ligandos de la familia eph biologicamente activos. Expired - Lifetime ES2192199T5 (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US22207594A 1994-04-04 1994-04-04
US222075 1994-04-04
US22940294A 1994-04-12 1994-04-12
US229402 1994-04-12
US08/299,567 US5747033A (en) 1993-10-28 1994-09-01 Method of enhancing the biological activity of Eph family ligands
US299567 1994-09-01
US32742394A 1994-10-21 1994-10-21
US327423 1994-10-21

Publications (2)

Publication Number Publication Date
ES2192199T3 true ES2192199T3 (es) 2003-10-01
ES2192199T5 ES2192199T5 (es) 2007-07-01

Family

ID=27499262

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95916204T Expired - Lifetime ES2192199T5 (es) 1994-04-04 1995-04-04 Ligandos de la familia eph biologicamente activos.

Country Status (9)

Country Link
EP (1) EP0758381B2 (es)
JP (1) JP3686084B2 (es)
AT (1) ATE232901T1 (es)
AU (1) AU691915B2 (es)
CA (1) CA2187167A1 (es)
DE (1) DE69529674T3 (es)
ES (1) ES2192199T5 (es)
IL (1) IL113252A0 (es)
WO (1) WO1995027060A2 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824303A (en) * 1992-11-13 1998-10-20 Amgen Inc. Eck receptor ligands
US5624899A (en) * 1994-07-20 1997-04-29 Genentech Inc. Method for using Htk ligand
EP0787148B1 (en) * 1994-10-27 2004-04-07 Genentech, Inc. Al-1 neurotrophic factor, a ligand for an eph-related tyrosine kinase receptor
US5759775A (en) * 1994-10-27 1998-06-02 Genetech, Inc. Methods for detecting nucleic acids encoding AL--1 neurotrophic factor
EP1019728A1 (en) * 1995-10-13 2000-07-19 Mount Sinai Hospital Method of activating a novel ligand regulatory pathway
US6610296B2 (en) 1995-10-26 2003-08-26 Genentech, Inc. Methods of enhancing cognitive function using an AL-1 neurotrophic factor immunoadhesin
US6696557B1 (en) 1996-04-19 2004-02-24 Genentech, Inc. AL-2 neurotrophic factor nucleic acid
US6413730B1 (en) 1996-07-05 2002-07-02 Mount Sinai Hospital Corporation Method for identifying compounds that inhibit or enhance activation of a transmembrane ligand for a receptor tyrosine kinase
US5994112A (en) * 1996-10-09 1999-11-30 Incyte Pharmaceuticals, Inc. Human protein tyrosine kinase
CA2355163A1 (en) * 1998-12-18 2000-06-29 Mount Sinai Hospital Three dimensional structure of a sterile alpha motif domain
DE69924009T2 (de) * 1998-12-23 2006-04-13 Regeneron Pharmaceuticals, Inc. Methode zur verstärkung der biologischen aktivität von liganden
EP2789630A1 (en) 2013-04-09 2014-10-15 EngMab AG Bispecific antibodies against CD3e and ROR1
JP6708635B2 (ja) 2014-10-09 2020-06-10 エンクマフ エスアーエールエル ＣＤ３εおよびＲＯＲ１に対する二特異性抗体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151360A (en) * 1990-12-31 1992-09-29 Biomembrane Institute Effect of n,n,n-trimethylsphingosine on protein kinase-c activity, melanoma cell growth in vitro, metastatic potential in vivo and human platelet aggregation
AU685765B2 (en) * 1992-11-13 1998-01-29 Amgen, Inc. (Eck) receptor ligands
AU669960B2 (en) * 1992-11-13 1996-06-27 Immunex Corporation Novel cytokine designated elk ligand
US5516658A (en) * 1993-08-20 1996-05-14 Immunex Corporation DNA encoding cytokines that bind the cell surface receptor hek

Also Published As

Publication number Publication date
EP0758381A1 (en) 1997-02-19
JPH09511401A (ja) 1997-11-18
DE69529674T2 (de) 2003-12-18
ATE232901T1 (de) 2003-03-15
IL113252A0 (en) 1995-07-31
WO1995027060A2 (en) 1995-10-12
WO1995027060A3 (en) 1995-11-02
AU691915B2 (en) 1998-05-28
ES2192199T5 (es) 2007-07-01
DE69529674T3 (de) 2007-06-28
DE69529674D1 (de) 2003-03-27
EP0758381B2 (en) 2006-11-15
AU2278995A (en) 1995-10-23
JP3686084B2 (ja) 2005-08-24
CA2187167A1 (en) 1995-10-12
EP0758381B1 (en) 2003-02-19

Similar Documents

Publication Publication Date Title
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
CY1107821T1 (el) Πολυπεπτιδιο παραγοντα viii με ενεργοτητα παραγοντα viii:c
IL100343A0 (en) G protein coupled glutamate receptors
ATE389666T1 (de) Hohe expressionsrate von proteinen
BG104149A (bg) Белтъци, свързващи интерлевкин-18, тяхното получаване и приложение
DE69939327D1 (de) Funktionelle antagonisten von hedgehog-aktivität
FI104180B1 (fi) Menetelmä polypeptidin vasta-aineen ekä IL-4 välittämien tilojen hoitoon tarkoitetun seoksen valmistamiseksi
ATE110108T1 (de) Genetische modifizierung von endothelialen zellen.
UA84387C2 (ru) Человеческий цитокин как лиганд зальфа рецептора и его применение
ES8103976A1 (es) Un metodo de producir proteinas de interferon humano de for-ma le
BG103091A (en) Shortened soluble receptors of type i & ii of the tumour necrotizing factor
EP0218531A3 (en) Immunogenic peptides of human interleukin-1 and the corresponding anti-peptide antibodies
WO2002012345A3 (en) Soluble zcytor 11 cytokine receptors
SG65593A1 (en) Totally synthetic affinity reagents
ATE233788T1 (de) Interleukin-15-rezeptoren
DE69924009D1 (de) Methode zur verstärkung der biologischen aktivität von liganden
DE69935782D1 (de) Brustkrebsresistenzprotein (bcrp) und für dieses kodierende dna
ATE216723T1 (de) Hormones de croissance humaines mutantes et leur utilisation
DE69635667D1 (de) Biologisch aktive liganden der eph familie
DE59911530D1 (de) Zellpermeabilität-vermittelndes polypeptid
DE59814002D1 (de) Sekretion von tragergebundenen proteinen in das periplasma und in den extrazellulären raum
MXPA02011938A (es) Adn que codifica para un receptor de histamina de mamifero del subtipo h4.
ATE123056T1 (de) Ancrod-proteine, ihre herstellung und verwendung.
CA2236001A1 (en) Biologically active eph family ligands
ATE130872T1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.